Arcus Biosciences, Inc. 13F holders
Of the 44 funds followed here, 5 reported a position in Arcus Biosciences, Inc. in a 13F for the quarter ended 30 June 2026. The largest: FMR LLC, 4.0 million shares worth $124.9 million, 0.0% of its reported book. New this quarter: Millennium Management. Sold out: Renaissance Technologies, Point72 Asset Management.
| Fund | Shares | Value | Of its book | Change on the quarter | Status | Quarter ended | Filing |
|---|---|---|---|---|---|---|---|
| FMR LLC | 4,049,757 | $124.9 million | 0.0% | +2,884,505 | added | 30 June 2026 | 13F |
| Citadel Advisors | 3,162,257 | $97.5 million | 0.0% | +1,741,822 | added | 30 June 2026 | 13F |
| Geode Capital Management | 2,448,749 | $75.5 million | 0.0% | +196,382 | added | 30 June 2026 | 13F |
| Two Sigma Investments | 635,404 | $19.6 million | 0.0% | +322,714 | added | 30 June 2026 | 13F |
| Millennium Management | 133,110 | $4.1 million | 0.0% | +133,110 | new | 30 June 2026 | 13F |
| Renaissance Technologies | 0 | $0 | 0.0% | -424,700 | exited | 30 June 2026 | 13F |
| Point72 Asset Management | 0 | $0 | 0.0% | -129,273 | exited | 30 June 2026 | 13F |
Value is what the fund reported.
Read more
Change is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.Schedule 13D and 13G filed on the name, last twelve months
| Filed | Schedule | Who | Holding | Of the class | Event date | Rule or purpose | Filing |
|---|---|---|---|---|---|---|---|
| 26 March 2026 | 13G/A | The Vanguard Group and 1 other | 0 | 0.0% | 13 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 8 January 2026 | 13G/A | BlackRock, Inc. and 1 other | 12.7 million | 10.4% | 31 December 2025 | passive, institutional (13d-1(b)) | EDGAR |
| 14 November 2025 | 13G/A | Point72 Asset Management, L.P. and 5 others | 4.3 million | 4.1% | 30 September 2025 | passive, under 20% (13d-1(c)) | EDGAR |
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read more
Amendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short.Fails to deliver
| Settlement date | Shares failed | Price | File |
|---|---|---|---|
| 2 September 2026 | 91 | $29.71 | SEC |
| 31 August 2026 | 3,990 | $29.21 | SEC |
| 26 August 2026 | 8,867 | $31.57 | SEC |
| 24 August 2026 | 4,420 | $30.34 | SEC |
| 11 August 2026 | 8 | $28.72 | SEC |
| 10 August 2026 | 115 | $28.62 | SEC |
| 4 August 2026 | 3 | $27.62 | SEC |
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period.
Read more
Largest in the window: 8,867 on 26 August 2026. A fail is an operational fact about settlement, not a position.Source
Each fund's 13F-HR on EDGAR, linked per row; positions matched to RCUS by CUSIP from the SEC's own fails-to-deliver files; Schedule 13D and 13G from the company's own filing index, each read to confirm the company is the issuer named.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.